Advanced Company’s Lead Program, OTX-2002, in the Clinic; Preliminary Data from Phase 1/2 MYCHELANGELO™ I Trial Anticipated in 2023 Progressed IND-enabling Studies for OTX-2101; Company’s Development ...
Good morning. And welcome to the Omega Healthcare Investors Fourth Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s ...
Omega Healthcare Investors owns nursing homes, a property niche that was hard-hit by the COVID-19 pandemic. The stock has sold off sharply relative to pre-COVID times, but has massively outperformed ...
Adjusted funds from operations per share and funds available for distribution per share can be calculated using weighted-average common shares outstanding, diluted shown above. Nareit Funds From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results